Orthofix Medical Inc. Research and Development Expense
Orthofix Medical Inc. (OFIX) reported Research and Development Expense of $15.94 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-05
- Orthofix Medical Inc. research and development expense for the quarter ending 2026-06-30 was $15.94M, a 0.06% increase year-over-year.
- Orthofix Medical Inc. research and development expense for the quarter ending 2026-03-31 was $15.32M, a 22.49% decline year-over-year.
- Orthofix Medical Inc. research and development expense for the quarter ending 2025-12-31 was $15.37M, a 18.26% decline year-over-year.
- Orthofix Medical Inc. research and development expense for the quarter ending 2025-09-30 was $14.77M, a 14.57% decline year-over-year.
- Orthofix Medical Inc. research and development expense for fiscal 2025 was $65.85M, a 10.59% decline from fiscal 2024.
- Orthofix Medical Inc. research and development expense for fiscal 2024 was $73.64M, a 8.21% decline from fiscal 2023.
- Orthofix Medical Inc. research and development expense for fiscal 2023 was $80.23M, a 63.52% increase from fiscal 2022.
- Orthofix Medical Inc. research and development expense for fiscal 2022 was $49.06M, a 1.12% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $15.94M 10-Q · filed 2026-08-05 | $31.26M 10-Q · filed 2026-08-05 | $46.64M derived: sum of 3 quarters · filed 2026-08-05 | $61.41M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | $15.32M 10-Q · filed 2026-05-05 | $30.69M derived: sum of 2 quarters · filed 2026-05-05 | $45.47M derived: sum of 3 quarters · filed 2026-05-05 | $61.40M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $15.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $30.15M derived: sum of 2 quarters · filed 2026-02-24 | $46.08M derived: sum of 3 quarters · filed 2026-08-05 | $65.85M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $14.77M 10-Q · filed 2025-11-04 | $30.71M derived: sum of 2 quarters · filed 2026-08-05 | $50.47M 10-Q · filed 2025-11-04 | $69.28M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $15.93M 10-Q · filed 2026-08-05 | $35.70M 10-Q · filed 2026-08-05 | $54.51M derived: sum of 3 quarters · filed 2026-08-05 | $71.80M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $19.77M 10-Q · filed 2026-05-05 | $38.57M derived: sum of 2 quarters · filed 2026-05-05 | $55.87M derived: sum of 3 quarters · filed 2026-05-05 | $73.92M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $18.81M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $36.10M derived: sum of 2 quarters · filed 2026-02-24 | $54.15M derived: sum of 3 quarters · filed 2026-02-24 | $73.64M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $17.29M 10-Q · filed 2025-11-04 | $35.34M derived: sum of 2 quarters · filed 2025-11-04 | $54.84M 10-Q · filed 2025-11-04 | $73.78M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $18.05M 10-Q · filed 2025-08-05 | $37.54M 10-Q · filed 2025-08-05 | $56.48M derived: sum of 3 quarters · filed 2026-02-24 | $75.04M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $19.49M 10-Q · filed 2025-05-06 | $38.43M derived: sum of 2 quarters · filed 2026-02-24 | $56.99M derived: sum of 3 quarters · filed 2026-02-24 | $76.42M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $18.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $37.50M derived: sum of 2 quarters · filed 2026-02-24 | $56.92M derived: sum of 3 quarters · filed 2026-02-24 | $80.23M 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $18.56M 10-Q · filed 2024-11-07 | $37.98M derived: sum of 2 quarters · filed 2024-11-07 | $61.29M 10-Q · filed 2024-11-07 | $74.44M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | $19.42M 10-Q · filed 2024-08-06 | $42.73M 10-Q · filed 2024-08-06 | $55.88M derived: sum of 3 quarters · filed 2025-02-25 | $67.83M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | $23.31M 10-Q · filed 2024-05-07 | $36.46M derived: sum of 2 quarters · filed 2025-02-25 | $48.40M derived: sum of 3 quarters · filed 2025-02-25 | $61.16M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | $13.15M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $25.09M derived: sum of 2 quarters · filed 2025-02-25 | $37.85M derived: sum of 3 quarters · filed 2025-02-25 | $49.06M 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | $11.94M 10-Q · filed 2023-11-08 | $24.70M derived: sum of 2 quarters · filed 2023-11-08 | $35.91M 10-Q · filed 2023-11-08 | $49.16M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2022-06-30 | $12.76M 10-Q · filed 2023-08-08 | $23.97M 10-Q · filed 2023-08-08 | $37.21M derived: sum of 3 quarters · filed 2024-03-05 | $49.57M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2022-03-31 | $11.21M 10-Q · filed 2023-05-09 | $24.45M derived: sum of 2 quarters · filed 2024-03-05 | $36.81M derived: sum of 3 quarters · filed 2024-03-05 | $49.94M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2021-12-31 | $13.24M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $25.60M derived: sum of 2 quarters · filed 2024-03-05 | $38.72M derived: sum of 3 quarters · filed 2024-03-05 | $49.62M 10-K · filed 2024-03-05 | ||||
| 2021-09-30 | $12.36M 10-Q · filed 2022-11-03 | $25.48M derived: sum of 2 quarters · filed 2022-11-03 | $36.38M 10-Q · filed 2022-11-03 | $46.74M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-06-30 | $13.12M 10-Q · filed 2022-08-05 | $24.02M 10-Q · filed 2022-08-05 | $34.38M derived: sum of 3 quarters · filed 2023-03-06 | $44.34M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-03-31 | $10.90M 10-Q · filed 2022-05-06 | $21.26M derived: sum of 2 quarters · filed 2023-03-06 | $31.22M derived: sum of 3 quarters · filed 2023-03-06 | $39.99M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2020-12-31 | $10.37M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $20.33M derived: sum of 2 quarters · filed 2023-03-06 | $29.09M derived: sum of 3 quarters · filed 2023-03-06 | $39.06M 10-K · filed 2023-03-06 | ||||
| 2020-09-30 | $9.96M 10-Q · filed 2021-11-05 | $18.73M derived: sum of 2 quarters · filed 2021-11-05 | $28.69M 10-Q · filed 2021-11-05 | $37.14M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-06-30 | $8.77M 10-Q · filed 2021-08-06 | $18.73M 10-Q · filed 2021-08-06 | $27.18M derived: sum of 3 quarters · filed 2022-02-25 | $35.16M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2020-03-31 | $9.96M 10-Q · filed 2021-04-30 | $18.41M derived: sum of 2 quarters · filed 2022-02-25 | $26.39M derived: sum of 3 quarters · filed 2022-02-25 | $35.37M derived: sum of 4 quarters · filed 2022-02-25 | ||||
| 2019-12-31 | $8.45M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $16.43M derived: sum of 2 quarters · filed 2022-02-25 | $25.41M derived: sum of 3 quarters · filed 2022-02-25 | $34.64M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | $7.98M 10-Q · filed 2020-11-05 | $16.96M derived: sum of 2 quarters · filed 2020-11-05 | $26.19M 10-Q · filed 2020-11-05 | $34.98M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | $8.98M 10-Q · filed 2020-08-06 | $18.21M 10-Q · filed 2020-08-06 | $27.00M derived: sum of 3 quarters · filed 2021-02-26 | $36.60M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-03-31 | $9.23M 10-Q · filed 2020-05-08 | $18.02M derived: sum of 2 quarters · filed 2021-02-26 | $27.62M derived: sum of 3 quarters · filed 2021-02-26 | $35.51M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | $8.79M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $18.39M derived: sum of 2 quarters · filed 2021-02-26 | $26.28M derived: sum of 3 quarters · filed 2021-02-26 | $33.22M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | $9.60M 10-Q · filed 2019-10-28 | $17.49M derived: sum of 2 quarters · filed 2019-10-28 | $24.43M 10-Q · filed 2019-10-28 | $32.88M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | $7.89M 10-Q · filed 2019-08-05 | $14.83M 10-Q · filed 2019-08-05 | $23.28M derived: sum of 3 quarters · filed 2020-02-24 | $30.22M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | $6.94M 10-Q · filed 2019-05-06 | $15.39M derived: sum of 2 quarters · filed 2020-02-24 | $22.33M derived: sum of 3 quarters · filed 2020-02-24 | $29.21M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $8.45M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $15.39M derived: sum of 2 quarters · filed 2020-02-24 | $22.28M derived: sum of 3 quarters · filed 2020-02-24 | $29.70M 10-K · filed 2020-02-24 | ||||
| 2017-09-30 | $6.93M 10-Q · filed 2018-10-29 | $13.82M derived: sum of 2 quarters · filed 2018-10-29 | $21.25M 10-Q · filed 2018-10-29 | $28.75M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-06-30 | $6.89M 10-Q · filed 2018-08-06 | $14.31M 10-Q · filed 2018-08-06 | $21.82M derived: sum of 3 quarters · filed 2019-02-25 | $28.68M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-03-31 | $7.42M 10-Q · filed 2018-04-30 | $14.93M derived: sum of 2 quarters · filed 2019-02-25 | $21.79M derived: sum of 3 quarters · filed 2019-02-25 | $28.59M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2016-12-31 | $7.51M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | $14.37M derived: sum of 2 quarters · filed 2019-02-25 | $21.16M derived: sum of 3 quarters · filed 2019-02-25 | $28.80M 10-K · filed 2019-02-25 | ||||
| 2016-09-30 | $6.86M 10-Q · filed 2017-10-30 | $13.65M derived: sum of 2 quarters · filed 2017-10-30 | $21.29M 10-Q · filed 2017-10-30 | $28.86M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-06-30 | $6.80M 10-Q · filed 2017-08-07 | $6.79M 10-Q · filed 2016-08-01 | $14.44M 10-Q · filed 2017-08-07 | $14.43M 10-Q · filed 2016-08-01 | $22.01M derived: sum of 3 quarters · filed 2018-02-26 | $28.53M derived: sum of 4 quarters · filed 2018-02-26 | ||
| 2016-03-31 | $7.64M 10-Q · filed 2017-05-04 | $7.64M 10-Q · filed 2016-04-28 | $15.21M derived: sum of 2 quarters · filed 2018-02-26 | $21.73M derived: sum of 3 quarters · filed 2018-02-26 | $28.18M derived: sum of 4 quarters · filed 2018-02-26 | |||
| 2015-12-31 | $7.57M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $14.09M derived: sum of 2 quarters · filed 2018-02-26 | $20.54M derived: sum of 3 quarters · filed 2018-02-26 | $26.39M 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | $6.52M 10-Q · filed 2016-10-31 | $12.97M derived: sum of 2 quarters · filed 2016-10-31 | $18.82M 10-Q · filed 2016-10-31 | $25.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $6.45M 10-Q · filed 2016-08-01 | $12.30M 10-Q · filed 2016-08-01 | $18.47M derived: sum of 3 quarters · filed 2017-02-27 | $25.04M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $5.84M 10-Q · filed 2016-04-28 | $12.02M derived: sum of 2 quarters · filed 2017-02-27 | $18.59M derived: sum of 3 quarters · filed 2017-02-27 | $24.91M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $6.18M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $12.75M derived: sum of 2 quarters · filed 2017-02-27 | $19.06M derived: sum of 3 quarters · filed 2017-02-27 | $24.99M 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $6.57M 10-Q · filed 2015-11-03 | $12.88M derived: sum of 2 quarters · filed 2015-11-03 | $18.82M 10-Q · filed 2015-11-03 | $24.93M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $6.31M 10-Q · filed 2015-08-04 | $12.25M 10-Q · filed 2015-08-04 | $18.36M derived: sum of 3 quarters · filed 2016-02-29 | $24.72M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $5.93M 10-Q · filed 2015-05-18 | $5.94M 10-Q · filed 2014-05-08 | $12.05M derived: sum of 2 quarters · filed 2016-02-29 | $18.41M derived: sum of 3 quarters · filed 2016-02-29 | $26.96M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $6.12M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $12.48M derived: sum of 2 quarters · filed 2016-02-29 | $21.03M derived: sum of 3 quarters · filed 2016-02-29 | $26.77M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $6.36M 10-Q · filed 2015-03-31 | $14.91M derived: sum of 2 quarters · filed 2015-03-31 | $20.65M 10-Q · filed 2015-03-31 | $26.07M derived: sum of 4 quarters · filed 2015-04-29 | ||||
| 2013-06-30 | $8.55M 10-Q · filed 2015-03-31 | $14.29M 10-Q · filed 2015-03-31 | $19.71M derived: sum of 3 quarters · filed 2015-04-29 | $26.57M derived: sum of 4 quarters · filed 2015-04-29 | ||||
| 2013-03-31 | $5.74M 10-Q/A · filed 2015-03-31 | $5.40M 10-Q · filed 2013-05-09 | $11.16M derived: sum of 2 quarters · filed 2015-04-29 | $18.02M derived: sum of 3 quarters · filed 2015-04-29 | $27.27M derived: sum of 4 quarters · filed 2015-04-29 | |||
| 2012-12-31 | $5.42M derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-29 | $12.28M derived: sum of 2 quarters · filed 2015-04-29 | $21.53M derived: sum of 3 quarters · filed 2015-04-29 | $28.58M 10-K · filed 2015-04-29 | ||||
| 2012-09-30 | $6.86M 10-Q · filed 2014-03-25 | $16.11M derived: sum of 2 quarters · filed 2014-03-25 | $23.16M 10-Q · filed 2014-03-25 | $28.37M derived: sum of 4 quarters · filed 2015-03-31 | ||||
| 2012-06-30 | $9.25M 10-Q · filed 2014-03-24 | $16.30M 10-Q · filed 2014-03-24 | $21.51M derived: sum of 3 quarters · filed 2015-03-31 | $27.49M derived: sum of 4 quarters · filed 2015-03-31 | ||||
| 2012-03-31 | $7.05M 10-Q/A · filed 2014-03-24 | $7.75M 10-Q · filed 2012-05-04 | $12.26M derived: sum of 2 quarters · filed 2015-03-31 | $18.24M derived: sum of 3 quarters · filed 2015-03-31 | $24.47M derived: sum of 4 quarters · filed 2015-03-31 | |||
| 2011-12-31 | $5.21M derived: 10-K/A 12 month − 10-Q 9 month · filed 2015-03-31 | $11.19M derived: sum of 2 quarters · filed 2015-03-31 | $17.42M derived: sum of 3 quarters · filed 2015-03-31 | $22.86M 10-K/A · filed 2015-03-31 | $25.15M 10-K · filed 2012-02-29 | |||
| 2011-09-30 | $5.98M 10-Q · filed 2012-11-02 | $6.55M 10-Q · filed 2011-10-31 | $12.21M derived: sum of 2 quarters · filed 2012-11-02 | $17.66M 10-Q · filed 2012-11-02 | $19.37M 10-Q · filed 2011-10-31 | $22.95M derived: sum of 4 quarters · filed 2014-03-24 | ||
| 2011-06-30 | $6.23M 10-Q · filed 2012-07-30 | $6.77M 10-Q · filed 2011-08-05 | $11.67M 10-Q · filed 2012-07-30 | $12.82M 10-Q · filed 2011-08-05 | $16.97M derived: sum of 3 quarters · filed 2014-03-24 | $24.34M derived: sum of 4 quarters · filed 2014-03-24 | ||
| 2011-03-31 | $6.05M 10-Q · filed 2012-05-04 | $10.74M derived: sum of 2 quarters · filed 2014-03-24 | $18.11M derived: sum of 3 quarters · filed 2014-03-24 | $26.48M derived: sum of 4 quarters · filed 2014-03-24 | ||||
| 2010-12-31 | $4.69M derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-03-24 | $12.06M derived: sum of 2 quarters · filed 2014-03-24 | $20.43M derived: sum of 3 quarters · filed 2014-03-24 | $27.96M 10-K/A · filed 2014-03-24 | $30.35M 10-K · filed 2012-02-29 | |||
| 2010-09-30 | $7.38M 10-Q · filed 2011-10-31 | $15.74M derived: sum of 2 quarters · filed 2011-10-31 | $23.27M 10-Q · filed 2011-10-31 | |||||
| 2010-06-30 | $8.37M 10-Q · filed 2011-08-05 | $15.90M 10-Q · filed 2011-08-05 | ||||||
| 2009-12-31 | $31.46M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |